These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16380283)
1. [Chemotherapy in soft tissue sarcomas]. Zelek L Cancer Radiother; 2006; 10(1-2):68-71. PubMed ID: 16380283 [TBL] [Abstract][Full Text] [Related]
2. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798 [TBL] [Abstract][Full Text] [Related]
3. Role of chemotherapy in patients with soft tissue sarcomas. Maki RG Expert Rev Anticancer Ther; 2004 Apr; 4(2):229-36. PubMed ID: 15056053 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven. Blay JY; Le Cesne A Oncologist; 2009 Oct; 14(10):1013-20. PubMed ID: 19808771 [TBL] [Abstract][Full Text] [Related]
5. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Schuetze SM; Patel S Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770 [TBL] [Abstract][Full Text] [Related]
6. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY; J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas. Scurr M; Judson I Hematol Oncol Clin North Am; 2005 Jun; 19(3):489-500, vi. PubMed ID: 15939193 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas. Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704 [TBL] [Abstract][Full Text] [Related]
9. Advances in chemotherapy for patients with extremity soft tissue sarcoma. Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108 [TBL] [Abstract][Full Text] [Related]
10. [Adjuvant chemotherapy in the treatment of sarcomas]. Fayette J; Blay JY Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312 [TBL] [Abstract][Full Text] [Related]
11. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy. King JJ; Fayssoux RS; Lackman RD; Ogilvie CM Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963 [TBL] [Abstract][Full Text] [Related]
12. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813 [TBL] [Abstract][Full Text] [Related]
13. Preoperative and postoperative chemotherapy with ifosfamide and adriamycin for adult high-grade soft-tissue sarcomas in the extremities: Japan Clinical Oncology Group Study JCOG0304. Tanaka K; Kawamoto H; Saito I; Yoshimura K; Fukuda H; Iwamoto Y Jpn J Clin Oncol; 2009 Apr; 39(4):271-3. PubMed ID: 19155282 [TBL] [Abstract][Full Text] [Related]